Spinal implant maker NuVasive (NUVA +17%) pops after its Q1 results easily beat estimates,...

|By:, SA News Editor

Spinal implant maker NuVasive (NUVA +17%) pops after its Q1 results easily beat estimates, coming in at the high end of the expected range. Revenue jumped 21% Y/Y on strong sales of its minimally invasive spinal surgery products. William Blair and Baird both upgrade the stock on the back of the better than expected results.